This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB06830/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB06830/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06830/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB06830/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB06830/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06830
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB06830 n14:DB06830
dcterms:title
(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)
adms:identifier
n9:99443301 n10:028 n11:5276520 n12:4440481 n13:DB06830
n3:IUPAC-Name
n4:271B55F7-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B55FD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B55FC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B55F9-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B55FA-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B55FB-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B55F5-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B55F6-363D-11E5-9242-09173F13E4C5 n4:271B55F3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B55F4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5603-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5604-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B55FE-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B55FF-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5601-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5600-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5602-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5609-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B560B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B560C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5608-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5607-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B560A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B55F8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5605-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5606-363D-11E5-9242-09173F13E4C5